Company profile for Persica Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Persica Pharmaceuticals aims to bring forward a new therapy to treat patients suffering from Chronic Lower Back Pain (CLBP), a debilitating condition that significantly affects quality of life for which existing treatments are often ineffective. Building on ground-breaking research. which has demonstrated that Chronic Lower Back Pain (CLBP) can be caused by bacterial infection and treated with antibiotics, Persica Pharmaceutic...
Persica Pharmaceuticals aims to bring forward a new therapy to treat patients suffering from Chronic Lower Back Pain (CLBP), a debilitating condition that significantly affects quality of life for which existing treatments are often ineffective. Building on ground-breaking research. which has demonstrated that Chronic Lower Back Pain (CLBP) can be caused by bacterial infection and treated with antibiotics, Persica Pharmaceuticals aims to bring forward a new treatment to alleviate this serious and debilitating condition.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
7 Denne Hill Business Centre, Womenswold, Canterbury, Kent CT4 6HD
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/06/11/3097279/0/en/Persica-strengthens-global-IP-portfolio-with-EU-patent-granted-for-PP353.html

GLOBENEWSWIRE
11 Jun 2025

https://www.globenewswire.com/news-release/2025/03/05/3037123/0/en/Persica-Pharmaceuticals-announces-positive-Phase-1b-clinical-data-for-PP353-a-novel-non-opioid-intradiscal-injection-for-the-treatment-of-chronic-Low-Back-Pain.html

GLOBENEWSWIRE
05 Mar 2025

https://www.globenewswire.com/news-release/2024/11/19/2983276/0/en/Persica-Pharmaceuticals-research-published-in-Journal-of-Orthopaedic-Research-Spine-ahead-of-anticipated-clinical-data-in-2025.html

GLOBENEWSWIRE
19 Nov 2024

https://www.globenewswire.com//news-release/2024/03/07/2841957/0/en/Persica-Pharmaceuticals-completes-recruitment-into-Modic-Trial-assessing-efficacy-of-PP353-to-treat-chronic-lower-back-pain.html

GLOBENEWSWIRE
07 Mar 2024

https://www.globenewswire.com/news-release/2022/03/24/2409129/0/en/Peter-Hamlyn-Founder-and-Director-of-Persica-Pharmaceuticals-will-be-presenting-at-the-British-Association-of-Spine-Surgeons.html

GLOBENEWSWIRE
24 Mar 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty